BRCA2 and breast cancer: The GPS score had a protective effect in the whole BRCA1 population and in the ovulating strata (RH 0.76/0.58, p > 0.015), and was associated to a higher hazard of breast cancer in the BRCA2 whole population (RH = 1.33, p = 0.035).